NCT00409708
Effects of Methylphenidate on Cellular Abnormalities in Children With Attention Deficit Hyperactivity Disorder (ADHD)
See it on ClinicalTrials.gov ↗104 people
36.5%
63.5%
38 womenmiddle line = equal numbers66 men
- Phase
- PHASE2
- Paid for by
- Novartis
- Finished
- —
- Health conditions
- Attention Deficit Hyperactivity Disorder
- Who could join
- Anyone
- Ages
- 6 Years – 12 Years
- Average age
- mean 8.4 years
- Age 65+
- 0%
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- Age limit under 65
Older women were turned away, even though they often take this medicine.
“Maximum age: 12 Years.”
- No seizures
Women with epilepsy or past seizures were turned away.
“History of seizures (except childhood febrile seizures)”
- No cancer
Women with current or past cancer were turned away.
“History of malignant neoplasm”
Study titles and rules are shown in their original English.